MGX

Metagenomi Therapeutics, Inc

• Dow Jones·07/07 11:08

  Metagenomi Price Target Cut to $5.00/Share From $7.00 by Chardan Capital

• Dow Jones·07/07 11:08

  Metagenomi Is Maintained at Buy by Chardan Capital

• Benzinga·07/07 10:59

  Chardan Capital Maintains Buy on Metagenomi Therapeutics, Lowers Price Target to $5

• TipRanks·07/07 10:40

  Metagenomi transferred with a Buy at Chardan

• TipRanks·06/10 10:51

  Metagenomi Announces Board Changes and Shareholder Meeting Results

• PUBT·06/10 10:01

  Metagenomi Therapeutics shareholders elect Eckhardt, Bjerkholt as Class II directors

• Simply Wall St·05/14 13:33

  Analysts Have Lowered Expectations For Metagenomi Therapeutics, Inc. (NASDAQ:MGX) After Its Latest Results

• TipRanks·05/13 23:20

  Analysts Are Bullish on Top Healthcare Stocks: Metagenomi, Inc. (MGX), Sionna Therapeutics, Inc. (SION)

• Dow Jones·05/12 13:37

  Metagenomi Price Target Cut to $9.00/Share From $12.00 by Wells Fargo

• Dow Jones·05/12 13:37

  Metagenomi Is Maintained at Overweight by Wells Fargo

• Benzinga·05/12 13:27

  Wells Fargo Maintains Overweight on Metagenomi Therapeutics, Lowers Price Target to $9

• Reuters·05/12 11:45

  METAGENOMI THERAPEUTICS, INC. <MGX.O>: WELLS FARGO CUTS TARGET PRICE TO $9 FROM $12

• TipRanks·05/12 10:38

  Wells Fargo Keeps Their Buy Rating on Metagenomi, Inc. (MGX)

• TipRanks·05/12 10:27

  Metagenomi price target lowered to $9 from $12 at Wells Fargo

• Reuters·05/12 07:21

  U.S. RESEARCH ROUNDUP-Accuray, Aevex, Zoetis